Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 21 09:56AM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.06 Insider Own26.14% Shs Outstand57.91M Perf Week-16.29%
Market Cap132.78M Forward P/E- EPS next Y-1.42 Insider Trans-0.22% Shs Float44.37M Perf Month-41.99%
Income-55.94M PEG- EPS next Q-0.28 Inst Own63.81% Short Float1.60% Perf Quarter-48.96%
Sales0.00M P/S- EPS this Y-7.39% Inst Trans4.20% Short Ratio2.50 Perf Half Y-30.94%
Book/sh4.36 P/B0.51 EPS next Y-22.04% ROA-22.89% Short Interest0.71M Perf Year-61.30%
Cash/sh4.20 P/C0.53 EPS next 5Y-0.20% ROE-25.36% 52W Range1.81 - 11.31 Perf YTD-42.45%
Dividend Est.- P/FCF- EPS past 5Y-54.03% ROI-19.12% 52W High-80.46% Beta0.07
Dividend TTM- Quick Ratio30.20 Sales past 5Y-28.84% Gross Margin- 52W Low22.09% ATR (14)0.18
Dividend Ex-Date- Current Ratio30.20 EPS Y/Y TTM4.53% Oper. Margin0.00% RSI (14)23.68 Volatility6.75% 6.96%
Employees52 Debt/Eq0.12 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price12.80
Option/ShortYes / Yes LT Debt/Eq0.12 EPS Q/Q9.76% Payout- Rel Volume0.46 Prev Close2.21
Sales Surprise- EPS Surprise4.18% Sales Q/Q- EarningsMay 14 BMO Avg Volume283.67K Price2.21
SMA20-21.18% SMA50-30.86% SMA200-36.87% Trades Volume14,630 Change0.00%
Date Action Analyst Rating Change Price Target Change
Dec-12-23Initiated Deutsche Bank Buy $8
Jul-20-23Resumed BofA Securities Buy $9 → $14
May-18-23Initiated Cantor Fitzgerald Overweight $13
Jul-15-22Initiated BTIG Research Buy $15
Jun-30-22Initiated H.C. Wainwright Buy $15
Jan-21-22Upgrade BofA Securities Neutral → Buy $16 → $14
Jul-26-21Initiated UBS Buy $27
Jul-26-21Initiated Stifel Buy $27
Jul-26-21Initiated Credit Suisse Outperform $26
Jul-26-21Initiated BofA Securities Neutral $20
May-15-24 03:00AM
May-14-24 11:53AM
May-13-24 04:00PM
10:15AM Loading…
May-08-24 05:47PM
May-07-24 04:00PM
Apr-19-24 12:13PM
Apr-16-24 08:00AM
Apr-08-24 05:38PM
Apr-04-24 02:12PM
08:38AM Loading…
Apr-03-24 08:38AM
Mar-28-24 12:00PM
Mar-27-24 09:46AM
Mar-26-24 09:20PM
Mar-21-24 10:41AM
Mar-19-24 04:00PM
Mar-18-24 10:31AM
Mar-12-24 04:00PM
Mar-08-24 08:50AM
Feb-29-24 09:40AM
Feb-21-24 08:00AM
Feb-01-24 07:00AM
02:14PM Loading…
Jan-30-24 02:14PM
Jan-24-24 01:58PM
Jan-04-24 04:15PM
Nov-14-23 08:53AM
Nov-13-23 11:08PM
Nov-07-23 04:01PM
Nov-06-23 04:01PM
Nov-02-23 04:00PM
Oct-27-23 09:25AM
Oct-04-23 08:00AM
Sep-19-23 04:00PM
Sep-06-23 04:00PM
Aug-08-23 10:21PM
Aug-01-23 04:00PM
Jul-25-23 01:47PM
Jul-18-23 10:31PM
Jul-17-23 04:53PM
Jul-16-23 03:00AM
Jul-03-23 05:13PM
Jun-28-23 06:30AM
Jun-13-23 07:00AM
May-16-23 12:41PM
May-09-23 07:00AM
May-04-23 04:01PM
May-02-23 04:01PM
Apr-09-23 08:57AM
Mar-29-23 07:30AM
Mar-28-23 08:00AM
Mar-27-23 07:00AM
Mar-22-23 04:01PM
Mar-20-23 04:01PM
Mar-08-23 04:01PM
Feb-15-23 12:07PM
Feb-13-23 08:00AM
Jan-06-23 09:40AM
Jan-04-23 08:00AM
Dec-29-22 06:02AM
Nov-14-22 04:01PM
Nov-09-22 04:01PM
Nov-07-22 04:01PM
Nov-01-22 08:00AM
Oct-24-22 08:00AM
Sep-08-22 12:44PM
Aug-15-22 11:00PM
Aug-08-22 04:15PM
Aug-01-22 10:30AM
Jul-26-22 04:15PM
Jun-08-22 08:00AM
May-16-22 10:00PM
May-11-22 05:08PM
Apr-27-22 08:00AM
Apr-02-22 12:00AM
Apr-01-22 05:01PM
Mar-28-22 04:05PM
Mar-16-22 04:15PM
Dec-30-21 04:16AM
Nov-25-21 07:35AM
Nov-15-21 08:00AM
Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which discovers and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Charlottesville, VA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
OConnell Daniel JosephPresident and CEOJan 19 '24Sale3.4715,20052,753502,485Jan 19 07:07 PM
Meisner Derek MChief Legal Officer & Corp SecJan 19 '24Sale3.488,93331,048108,867Jan 19 07:06 PM
Zuga MattCFO & Chief Business OfficerJan 18 '24Sale3.714,24215,717211,445Jan 19 07:05 PM
Siemers EricChief Medical OfficerJan 18 '24Sale3.713,12411,604117,576Jan 19 07:05 PM
Barton RussellChief Operating OfficerJan 18 '24Sale3.732,83310,55596,867Jan 19 07:04 PM
Ives Jeffrey L.DirectorAug 17 '23Option Exercise0.7541,94931,51939,149Aug 18 06:31 PM
Ives Jeffrey L.DirectorAug 17 '23Sale6.4941,949272,3340Aug 18 06:31 PM
RA CAPITAL MANAGEMENT, L.P.DirectorJul 21 '23Buy7.755,161,29039,999,99813,043,179Jul 25 04:30 PM